119
Views
20
CrossRef citations to date
0
Altmetric
Review

Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes

, , &
Pages 143-151 | Published online: 29 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tuang Yeow Poh, Micheál Mac Aogáin, Adrian Kwok Wai Chan, Anthony Chau Ang Yii, Valerie Fei Lee Yong, Pei Yee Tiew, Mariko Siyue Koh & Sanjay Haresh Chotirmall. (2017) Understanding COPD-overlap syndromes. Expert Review of Respiratory Medicine 11:4, pages 285-298.
Read now
Maria Gabriella Matera, Paola Rogliani, Josuel Ora, Luigino Calzetta & Mario Cazzola. A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome. Expert Opinion on Investigational Drugs 0:0.
Read now

Articles from other publishers (17)

Alessandro N. Franciosi, James Ralph, Naoimh J. O'Farrell, Colm Buckley, Christian Gulmann, Marina O'Kane, Tomás P. Carroll & Noel G. McElvaney. (2022) Alpha-1 antitrypsin deficiency–associated panniculitis. Journal of the American Academy of Dermatology 87:4, pages 825-832.
Crossref
Xiao Liu, Kevin Vanvarenberg, Kobenan Guy Wilfried Kouassi, Sohaib Mahri & Rita Vanbever. (2022) Production and characterization of mono-PEGylated alpha-1 antitrypsin for augmentation therapy. International Journal of Pharmaceutics 612, pages 121355.
Crossref
Grace Hogan, Pierce Geoghegan, Tomás P. Carroll, Jennifer Clarke, Oisín F. McElvaney, Oliver J. McElvaney, Noel G. McElvaney & Gerard F. Curley. (2021) α1-Antitrypsin: Key Player or Bystander in Acute Respiratory Distress Syndrome?. Anesthesiology 134:5, pages 792-808.
Crossref
Erik Tambuyzer, Benjamin Vandendriessche, Christopher P. Austin, Philip J. Brooks, Kristina Larsson, Katherine I. Miller Needleman, James Valentine, Kay Davies, Stephen C. Groft, Robert Preti, Tudor I. Oprea & Marco Prunotto. (2019) Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nature Reviews Drug Discovery 19:2, pages 93-111.
Crossref
Martin Zamora. (2019) Surgery for patients with Alpha 1 Antitrypsin Deficiency: A review. The American Journal of Surgery 218:3, pages 639-647.
Crossref
Judith A. Newell, Christine Donahue & D. Kyle Hogarth. (2019) An NP's guide to diagnosing and treating alpha-1 antitrypsin deficiency. The Nurse Practitioner 44:4, pages 13-21.
Crossref
Ingrid M. Verhamme, Sarah E. Leonard & Ray C. Perkins. 2019. Functional Proteomics. Functional Proteomics 313 392 .
A.P. Lopes, M.A. Mineiro, F. Costa, J. Gomes, C. Santos, C. Antunes, D. Maia, R. Melo, M. Canotilho, E. Magalhães, I. Vicente, C. Valente, B.G. Gonçalves, B. Conde, C. Guimarães, C. Sousa, J. Amado, M.E. Brandão, M. Sucena, M.J. Oliveira, S. Seixas, V. Teixeira & L. Telo. (2018) Portuguese consensus document for the management of alpha-1-antitrypsin deficiency. Pulmonology 24, pages 1-21.
Crossref
Yoshiki Morifuji, Jian Xu, Noriko Karasaki, Kazuhiro Iiyama, Daisuke Morokuma, Masato Hino, Akitsu Masuda, Takumi Yano, Hiroaki Mon, Takahiro Kusakabe & Jae Man Lee. (2018) Expression, Purification, and Characterization of Recombinant Human α1-Antitrypsin Produced Using Silkworm–Baculovirus Expression System. Molecular Biotechnology 60:12, pages 924-934.
Crossref
Gabriel Thabut & Luciano Corda. (2018) Epidemiology, Diagnosis and Available Treatment for Alpha 1 Antitrypsin Deficiency-related Emphysema in Europe. European Respiratory & Pulmonary Diseases 4:1, pages 25.
Crossref
Dieter Köhler. (2017) Alpha-1-Antitrypsin-Mangel: Ist die Substitution ein Mythos?. Deutsches Ärzteblatt Online.
Crossref
Kate McKeage & Katherine A. Lyseng-Williamson. (2016) Human α1-proteinase inhibitor (Respreeza®) in α1-antitrypsin deficiency emphysema: a guide to its use in the EU. Drugs & Therapy Perspectives 32:10, pages 422-427.
Crossref
Cormac McCarthy, Emer P. Reeves & Noel G. McElvaney. (2016) The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency. Annals of the American Thoracic Society 13:Supplement_4, pages S297-S304.
Crossref
Catherine M. Greene, Stefan J. Marciniak, Jeffrey Teckman, Ilaria Ferrarotti, Mark L. Brantly, David A. Lomas, James K. Stoller & Noel G. McElvaney. (2016) α1-Antitrypsin deficiency. Nature Reviews Disease Primers 2:1.
Crossref
Amit Gaggar, Junliang Chen, James F. Chmiel, Henry L. Dorkin, Patrick A. Flume, Rhonda Griffin, David Nichols & Scott H. Donaldson. (2016) Inhaled alpha 1 -proteinase inhibitor therapy in patients with cystic fibrosis. Journal of Cystic Fibrosis 15:2, pages 227-233.
Crossref
Joanna WozniakTomasz WandtkePiotr KopinskiJoanna Chorostowska-Wynimko. (2015) Challenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene Therapy. Human Gene Therapy 26:11, pages 709-718.
Crossref
Franz von Nussbaum & Volkhart M.-J. Li. (2015) Neutrophil elastase inhibitors for the treatment of (cardio)pulmonary diseases: Into clinical testing with pre-adaptive pharmacophores. Bioorganic & Medicinal Chemistry Letters 25:20, pages 4370-4381.
Crossref